Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment

NCT02287298 is registered in ClinicalTrials.gov with The Retina Center of St. Louis County, PC as lead sponsor.

NCT NCT02287298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02287298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Triple Combination Therapy of Choroidal Neovascularization in Exudative Age-related Macular Degeneration - a Cost Effect and Efficient Therapeutic Treatment
Lead sponsor
The Retina Center of St. Louis County, PC
Phase
Observational
Overall status
Completed
Start date
August 31, 2014
Completion date
December 31, 2015
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exudative macular degeneration